(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REAL MEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

REAL MEDICINE

ST13

US500000077784738

Class

41, 44

Filing

77784738

Registration

3939503

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

02/24/2022

Trademark type

Word

Nice classes

41, 44

Filing date

07/20/2009

Registration date

04/05/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/24/2022

Last transaction

02/24/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

02/01/2008

First use in commerce

02/01/2008

Drawing code

4

Owner type

99

Owner location

Los Angeles, CA, US

Examiner

KEAM, ALEX S

Law office

M50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Real Medicine Inc.
Real Medicine Inc.

Representatives

Perry J. Viscounty LATHAM & WATKINS LLP

Technical classification

Nice Classes

Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

charitable servicesproviding toys to victims of diseases and disasters; providing a website with online information related to the aforementioned services

Class 44

charitable servicesproviding soap and personal hygiene items to victims of diseases and disasters; providing a website with online information related to the aforementioned services

Publications

History of USPTO decisions and trademark events.

33 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/24/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/24/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/24/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/24/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

09/28/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/05/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/07/2016

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/06/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/06/2016

E815

TEAS SECTION 8 & 15 RECEIVED

05/25/2016

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/31/2011

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/31/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

04/05/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/18/2011

PUBO

PUBLISHED FOR OPPOSITION

01/18/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/10/2010

ALIE

ASSIGNED TO LIE

12/10/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/18/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/18/2010

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/18/2010

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/20/2010

GNFR

FINAL REFUSAL E-MAILED

05/20/2010

CNFR

FINAL REFUSAL WRITTEN

05/20/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/29/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/28/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/28/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/29/2009

GNRT

NON-FINAL ACTION E-MAILED

10/29/2009

CNRT

NON-FINAL ACTION WRITTEN

10/29/2009

DOCK

ASSIGNED TO EXAMINER

10/21/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/23/2009

NWAP

NEW APPLICATION ENTERED

07/23/2009

Continuous trademark protection

Get notified about every new filing that threatens REAL MEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.